Abbott (ABT) Sees Q4 Sales Growth in Low-Mid Single-Digit Range
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $94.12 +0.94%
Revenue Growth %: +9.8%
Financial Fact:
Research and development: 352M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +9.8%
Financial Fact:
Research and development: 352M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) said to see fourth-quarter sales growth in the low-to-mid single-digit range. Comments were made on the company's conference call this morning following
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Hyperscale Data acquires 48.5 acres to expand Michigan campus
- MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs
Create E-mail Alert Related Categories
GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
